Karuna Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 6 | -$3.04 | -$2.38 | -$2.85 |
| Q2 2024 | 2 | -$3.02 | -$3.02 | -$3.02 |
| Q3 2024 | 2 | -$3.17 | -$3.17 | -$3.17 |
| Q4 2024 | 2 | -$2.05 | -$2.05 | -$2.05 |
| Q1 2025 | 3 | -$2.62 | -$2.62 | -$2.62 |
| Q2 2025 | 3 | -$2.33 | -$2.33 | -$2.33 |
| Q3 2025 | 3 | -$2.01 | -$2.01 | -$2.01 |
| Q4 2025 | 3 | -$1.64 | -$1.64 | -$1.64 |
Karuna Therapeutics, Inc. Earnings Date And Information
Karuna Therapeutics, Inc. last posted its earnings results on Thursday, May 2nd, 2024. The company reported $-2.8 earnings per share for the quarter, topping analysts' consensus estimates of $-3 by $0.2. The company had revenue of 0 for the quarter and had revenue of 654,000 for the year. Karuna Therapeutics, Inc. has generated $-12 earnings per share over the last year ($-11.73 diluted earnings per share) and currently has a price-to-earnings ratio of -37.08. Karuna Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based on prior year's report dates.
Karuna Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/22/2024 | Q4 2023 | -$2.64 | -$3.01 | -0.37 | $862,423 | $0 |
| 11/02/2023 | Q3 2023 | -$2.74 | -$3.16 | -0.42 | $1.26 M | $0 |
| 08/03/2023 | Q2 2023 | -$2.76 | -$2.75 | 0.01 | $416,881 | $0 |
| 05/04/2023 | Q1 2023 | -$2.86 | -$2.47 | 0.39 | $654,000 | |
| 02/23/2023 | Q4 2022 | -$2.23 | -$2.22 | 0.01 | $7,143 | $5.28 M |
| 11/03/2022 | Q3 2022 | -$1.99 | -$2.13 | -0.14 | $916,667 | $81,000 |
| 08/08/2022 | Q2 2022 | -$2.02 | -$2.17 | -0.15 | $5.28 M | |
| 05/05/2022 | Q1 2022 | -$2.06 | -$1.93 | 0.13 | $0 | |
| 02/24/2022 | Q4 2021 | -$1.52 | -$0.94 | 0.58 | $7.78 M | $36.96 M |
| 11/04/2021 | Q3 2021 | -$1.40 | -$1.72 | -0.32 | $0 | |
| 08/05/2021 | Q2 2021 | -$1.24 | -$1.17 | 0.07 | $0 | |
| 05/06/2021 | Q1 2021 | -$1.06 | -$1.10 | -0.04 | $0 | |
| 02/25/2021 | Q4 2020 | -$0.91 | -$0.89 | 0.02 | $0 | |
| 11/05/2020 | Q3 2020 | -$0.76 | -$0.71 | 0.05 | $0 | |
| 08/05/2020 | Q2 2020 | -$0.44 | -$0.65 | -0.21 | $0 | |
| 05/07/2020 | Q1 2020 | -$0.45 | -$0.33 | 0.12 | $0 | |
| 03/24/2020 | Q4 2019 | -$0.47 | -$0.32 | 0.15 | $0 | |
| 11/07/2019 | Q3 2019 | -$0.51 | -$0.39 | 0.12 | $0 | |
| 08/08/2019 | Q2 2019 | -$146.02 | $0 | |||
| 03/30/2019 | Q1 2019 | -$0.56 | $0 |
Karuna Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Karuna Therapeutics, Inc.'s earnings date?
Karuna Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates.
-
Did Karuna Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Karuna Therapeutics, Inc. (:KRTX) reported $-2.8 earnings per share (EPS) to beat the analysts' consensus estimate of $-3 by $0.2.
-
How can I listen to Karuna Therapeutics, Inc.'s earnings conference call?
The conference call for Karuna Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Karuna Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Karuna Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Karuna Therapeutics, Inc. generate each year?
Karuna Therapeutics, Inc. (:KRTX) has a recorded annual revenue of $654,000.
-
How much profit does Karuna Therapeutics, Inc. generate each year?
Karuna Therapeutics, Inc. (:KRTX) has a recorded net income of $654,000. Karuna Therapeutics, Inc. has generated $-11.73 earnings per share over the last four quarters.
-
What is Karuna Therapeutics, Inc.'s price-to-earnings ratio?
Karuna Therapeutics, Inc. (:KRTX) has a price-to-earnings ratio of -37.08 and price/earnings-to-growth ratio is 4.97.
